title: Delayed onset of angioedema with angiotensin-converting enzyme inhibitors: case report and review of the literature.
abstract: The angiotensin-converting enzyme inhibitors have gained widespread application in the management of hypertension and congestive heart failure, and after myocardial infarction. They are generally considered safe drugs, but there are a number of reports of angioedema associated with their use. In general, angioedema occurs within hours to days after initiation of therapy, and only a limited number of reports document a delayed onset. Our patient experienced angioedema after 14 months of therapy with benazepril.
authors.affiliation: Department of Pharmacy, Methodist Hospital, Indianapolis, IN 46206, USA.
authors.forename: N B
authors.initials: NB
authors.lastname: O'Mara
authors.forename: E M
authors.initials: EM
authors.lastname: O'Mara
mesh_terms: D000368:Aged; D000799:Angioedema / Q000139:chemically induced* / Q000503:physiopathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001552:Benzazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D014060:Tongue Diseases / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; C044946:benazepril